HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingbin Liu Selected Research

Gallbladder Neoplasms (Gallbladder Cancer)

4/2022Correction to: Dihydroartemisinin inhibits TCTPdependent metastasis in gallbladder cancer.
12/2021Correction: EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway.
11/2021Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer.
10/2021SIRT3 inhibits gallbladder cancer by induction of AKT-dependent ferroptosis and blockade of epithelial-mesenchymal transition.
1/2021Rac GTPase activating protein 1 promotes gallbladder cancer via binding DNA ligase 3 to reduce apoptosis.
11/2020Long noncoding RNA lncGALM increases risk of liver metastasis in gallbladder cancer through facilitating N-cadherin and IL-1β-dependent liver arrest and tumor extravasation.
10/2020Overview of current targeted therapy in gallbladder cancer.
2/2020Betulinic acid induces apoptosis of gallbladder cancer cells via repressing SCD1.
1/2020DGCR5 Promotes Gallbladder Cancer by Sponging MiR-3619-5p via MEK/ERK1/2 and JNK/p38 MAPK Pathways.
9/2019Correction to: Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingbin Liu Research Topics

Disease

50Neoplasms (Cancer)
11/2021 - 11/2002
34Gallbladder Neoplasms (Gallbladder Cancer)
04/2022 - 06/2012
12Neoplasm Metastasis (Metastasis)
04/2022 - 11/2002
12Carcinoma (Carcinomatosis)
01/2020 - 09/2010
11Stomach Neoplasms (Stomach Cancer)
10/2019 - 01/2013
6Pancreatic Neoplasms (Pancreatic Cancer)
03/2022 - 03/2016
6Carcinogenesis
03/2021 - 01/2013
5Hepatocellular Carcinoma (Hepatoma)
01/2014 - 11/2002
3Cholangiocarcinoma
07/2021 - 01/2017
3Adenocarcinoma
01/2021 - 10/2019
2Hypoxia (Hypoxemia)
01/2021 - 01/2016
2Breast Neoplasms (Breast Cancer)
01/2021 - 12/2017
2Pathologic Processes
11/2020 - 03/2016
2Liver Neoplasms (Liver Cancer)
01/2020 - 03/2016
2Pancreatic Fistula (Pancreatic Fistulas)
02/2016 - 12/2013
1Down Syndrome (Down's Syndrome)
01/2021
1Thromboembolism
01/2021
1Atherosclerosis
01/2021
1COVID-19
10/2020
1Convalescence
10/2020
1Portal Hypertension
07/2020
1DiGeorge Syndrome (Syndrome, DiGeorge)
01/2020
1Lymphatic Metastasis
10/2017

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
01/2020 - 11/2002
9Biological ProductsIBA
11/2020 - 01/2013
5Pharmaceutical PreparationsIBA
03/2022 - 05/2014
4Phosphotransferases (Kinase)IBA
12/2021 - 12/2013
4Long Noncoding RNAIBA
11/2020 - 01/2015
4Messenger RNA (mRNA)IBA
10/2016 - 11/2002
3artenimol (dihydroartemisinin)IBA
04/2022 - 01/2017
3RNA (Ribonucleic Acid)IBA
11/2021 - 11/2019
3GemcitabineFDA Link
07/2021 - 01/2021
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 09/2010
3MicroRNAs (MicroRNA)IBA
01/2021 - 09/2016
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 01/2014
3Small Interfering RNA (siRNA)IBA
10/2013 - 10/2012
2Cadherins (E-Cadherin)IBA
10/2021 - 11/2020
2Oxaliplatin (Eloxatin)FDA LinkGeneric
07/2021 - 10/2019
2IntegrinsIBA
03/2021 - 05/2015
2Piwi-Interacting RNAIBA
01/2020 - 01/2020
2Anaphase-Promoting Complex-CyclosomeIBA
01/2020 - 01/2020
2Biomarkers (Surrogate Marker)IBA
10/2017 - 06/2016
2Thioridazine (Mellaril)FDA LinkGeneric
03/2017 - 05/2014
2Transcription Factors (Transcription Factor)IBA
01/2016 - 12/2013
2MatrinesIBA
06/2012 - 08/2003
1MidkineIBA
11/2021
1NAD (NADH)IBA
10/2021
1Lipid PeroxidesIBA
10/2021
1Histone Deacetylases (Histone Deacetylase)IBA
10/2021
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
10/2021
1Sirtuin 3IBA
10/2021
1PlatinumIBA
07/2021
1folfirinoxIBA
07/2021
1Methotrexate (Mexate)FDA LinkGeneric
05/2021
1Folic Acid AntagonistsIBA
05/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2021
1olaparibIBA
01/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
1Signaling Lymphocytic Activation Molecule Family Member 1IBA
01/2021
1CarbonatesIBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
01/2021
1Ether (Diethyl Ether)IBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1LipidsIBA
01/2021
1Lipoproteins (Lipoprotein)IBA
01/2021
1DNA Ligases (Ligases, DNA)IBA
01/2021
1PolymersIBA
01/2021
1Cell Adhesion MoleculesIBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1Ethylene Glycol (Monoethylene Glycol)IBA
01/2021
1GTPase-Activating Proteins (GTPase-Activating Protein)IBA
01/2021
1Betulinic AcidIBA
02/2020
1Peptide Hydrolases (Proteases)FDA Link
01/2020
1p38 Mitogen-Activated Protein KinasesIBA
01/2020
1Interferon Regulatory Factor-2 (Interferon Regulatory Factor 2)IBA
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2020
1Chemokine ReceptorsIBA
01/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1Oncogene Proteins (Oncogene Protein)IBA
01/2020
1Carrier Proteins (Binding Protein)IBA
01/2020
1methylcobalamin-coenzyme M methyltransferaseIBA
11/2019
1XELOXIBA
10/2019
1Capecitabine (Xeloda)FDA Link
10/2019
1liensinineIBA
06/2019
1karyopherin alpha 2IBA
01/2019
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2018
1AntioxidantsIBA
03/2018
1PolyphenolsIBA
03/2018
1TeaIBA
03/2018
1NucleotidesIBA
10/2017

Therapy/Procedure

12Therapeutics
11/2021 - 03/2014
7Drug Therapy (Chemotherapy)
07/2021 - 11/2015
2Gastrectomy
10/2019 - 07/2016
2Lymph Node Excision (Lymph Node Dissection)
01/2018 - 10/2014
2Pancreaticojejunostomy
02/2016 - 03/2002
2Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2016 - 10/2011
1Transplantation
10/2021
1Immunotherapy
01/2021
1Hepatectomy
07/2020